IL10 and neoplasm: Subpopulations of Treg can modulate the expression of inhibitory receptors and depletion signaling pathways of CD8+ T cells through IL-10 and IL-35, which leads to diminished tumor killing capacity (Figure 1; Sawant et al., 2019).